Chest Pain: When It Is a Heart Problem and When It Is Not

Chest pain is one of the most common reasons adults present to emergency departments in the United States, accounting for approximately 8 million emergency visits per year according to the Centers for Disease Control and Prevention (CDC). Not every episode signals a cardiac emergency — the chest houses structures from at least four organ systems, each capable of generating pain. Understanding how clinicians distinguish cardiac from non-cardiac causes is essential context for patients navigating the broader landscape of cardiology care.

Definition and Scope

Chest pain, in clinical terms, refers to any discomfort, pressure, tightness, burning, or aching sensation arising between the neck and the upper abdomen. The American Heart Association (AHA) classifies chest pain evaluation as a high-priority diagnostic challenge because its origins span cardiac, pulmonary, gastrointestinal, musculoskeletal, and psychogenic domains.

The stakes are high on both ends of the spectrum. Missing an acute myocardial infarction (AMI) carries serious mortality risk; equally, over-attributing benign chest pain to cardiac disease exposes patients to unnecessary invasive testing. The Agency for Healthcare Research and Quality (AHRQ) has identified chest pain risk stratification as a core patient safety challenge in emergency medicine.

Cardiac chest pain specifically refers to discomfort arising from ischemia (reduced blood flow to heart muscle), pericardial inflammation, aortic pathology, or arrhythmia-related hemodynamic stress. Each of these mechanisms produces a distinct clinical profile, which is why no single symptom description reliably confirms or excludes a cardiac cause.

How It Works

Cardiac Mechanisms

The heart generates pain through two primary pathways:

1. Ischemic pain — When coronary artery blockage reduces oxygen supply to myocardial tissue, metabolic byproducts (including bradykinin, adenosine, and lactate) activate cardiac nociceptors. These signals travel via sympathetic afferent fibers to spinal levels C7 through T4, which is why ischemic pain frequently radiates to the left arm, jaw, or neck rather than staying localized in the chest. This shared neural pathway is the basis for the concept of referred pain in cardiac disease, as described in Braunwald's Heart Disease, a foundational cardiovascular medicine reference.

2. Pericardial and aortic pain — Inflammation of the pericardial sac (pericarditis) stretches pain-sensitive pericardial fibers, producing sharp, pleuritic pain that worsens when lying flat. Aortic dissection activates a different set of pain receptors, typically producing a sudden, tearing pain radiating to the back — one of the most distinctive cardiac pain signatures in emergency medicine.

Non-Cardiac Mechanisms

Non-cardiac chest pain arises from structures sharing thoracic innervation:

• Gastrointestinal: Gastroesophageal reflux disease (GERD) produces acid-induced esophageal irritation that mimics ischemic burning. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) notes that esophageal spasm can generate chest pain indistinguishable from angina in some presentations.
• Pulmonary: Pleuritis, pneumothorax, and pulmonary embolism generate chest pain through pleural nerve activation or right heart strain.
• Musculoskeletal: Costochondritis (inflammation of the costal cartilage) and rib injuries produce reproducible chest wall tenderness that worsens with palpation — a finding almost never present in true ischemic pain.
• Psychogenic: Panic disorder and generalized anxiety generate chest tightness through hyperventilation-driven hypocapnia and sympathetic surge. The National Institute of Mental Health (NIMH) recognizes panic disorder as a condition frequently presenting with somatic chest symptoms.

Common Scenarios

Scenario 1: Classic Angina

A 58-year-old male reports substernal pressure radiating to the left arm, triggered by climbing two flights of stairs and relieved within 5 minutes of rest. This pattern — exertional, pressure-like, radiation, and prompt relief — corresponds to the Canadian Cardiovascular Society (CCS) definition of stable angina. An electrocardiogram (EKG) and cardiac stress test are the standard initial diagnostic steps.

Scenario 2: Acute Myocardial Infarction (AMI)

Ischemic pain lasting more than 20 minutes at rest, accompanied by diaphoresis, nausea, or syncope, is treated as AMI until proven otherwise. The AHA/ACC guidelines on STEMI management establish a door-to-balloon time target of 90 minutes for ST-elevation MI — a benchmark that underscores how time-critical cardiac diagnosis is.

Scenario 3: Musculoskeletal Chest Pain

A 32-year-old female with reproducible sharp pain at the left parasternal border, worsened by pressing on the chest wall, is a classic costochondritis presentation. No radiation, no diaphoresis, no exertional pattern, and point-tenderness on palpation shift the probability sharply away from ischemia.

Scenario 4: Pulmonary Embolism

Sudden pleuritic chest pain with shortness of breath and hypoxia in a post-surgical or immobilized patient requires immediate pulmonary embolism workup. This is a non-cardiac cause of acute chest pain that carries a mortality risk comparable to AMI; relevant context appears in the deep vein thrombosis and pulmonary embolism reference material.

Decision Boundaries

Clinicians apply structured risk-stratification tools rather than relying on symptom description alone. The three most referenced frameworks are:

1. HEART Score — Evaluates History, EKG findings, Age, Risk factors, and Troponin elevation. A HEART Score of 0–3 identifies a low-risk cohort with a major adverse cardiac event (MACE) rate below 2%, while a score of 7–10 corresponds to a MACE rate above 50% (Journal of Emergency Medicine, validated in multiple prospective cohorts).
2. TIMI Risk Score — Originally developed for unstable angina and NSTEMI, validated through the TIMI Study Group at Brigham and Women's Hospital.
3. Goldman Chest Pain Protocol — One of the earliest clinical decision rules for AMI risk, developed through prospective multicenter studies and still referenced in emergency medicine training.

The key distinction between cardiac and non-cardiac chest pain rests on four factors evaluated together — never in isolation:

Troponin biomarkers represent the biochemical boundary: elevated high-sensitivity troponin I or T — measured at 0 hours and 1–3 hours — indicates myocardial cell death and confirms a cardiac cause regardless of symptom presentation. The regulatory and clinical oversight context for these diagnostic standards is governed by FDA-cleared assay requirements and ACC/AHA guideline frameworks.

Atypical presentations are clinically recognized in diabetic patients, older adults, and females, who are more likely to present with fatigue, nausea, or jaw pain rather than classic substernal pressure. The AHA's Go Red for Women initiative has specifically documented this presentation disparity in peer-reviewed literature.

References

• Centers for Disease Control and Prevention — Emergency Department Visits
• American Heart Association — Chest Pain Resources
• Agency for Healthcare Research and Quality (AHRQ) — Patient Safety in Emergency Care
• National Institute of Diabetes and Digestive and Kidney Diseases — GERD
• National Institute of Mental Health — Panic Disorder
• AHA/ACC STEMI Guidelines (2013, updated)
• AHA Go Red for Women
• TIMI Study Group — Brigham and Women's Hospital

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)